Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Foot And Mouth Disease (FMD) Vaccine market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Foot And Mouth Disease (FMD) Vaccine market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Foot And Mouth Disease (FMD) Vaccine market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Foot And Mouth Disease (FMD) Vaccine products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Foot And Mouth Disease (FMD) Vaccine products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Foot And Mouth Disease (FMD) Vaccine market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Foot And Mouth Disease (FMD) Vaccine development has been the leading industry trend of Foot And Mouth Disease (FMD) Vaccine market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Foot And Mouth Disease (FMD) Vaccine Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Conventional Vaccines, Emergency Vaccines, Other |
| By Application Outlook |
Cattle, Sheep and goat, Pigs, Antelope, Deer, Bison, Camelids |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Agrovet market, Biog�nesis Bago, Vecol, FGBI - Federal Centre for Animal Health, Indian Immunologicals, Merial, VSVRI, FMD Center, Limor de Colombia |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Agrovet market
- Biog�nesis Bago
- Vecol
- FGBI - Federal Centre for Animal Health
- Indian Immunologicals
- Merial
- VSVRI
- FMD Center
- Limor de Colombia
Foot And Mouth Disease (FMD) Vaccine Market, By Type
- Conventional Vaccines
- Emergency Vaccines
- Other
Foot And Mouth Disease (FMD) Vaccine Market, By Application
- Cattle
- Sheep and goat
- Pigs
- Antelope
- Deer
- Bison
- Camelids
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Foot and Mouth Disease (FMD) Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size Growth Rate by Product
1.4.2 Conventional Vaccines
1.4.3 Emergency Vaccines
1.5 Market by End User
1.5.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size Growth Rate by End User
1.5.2 Cattle
1.5.3 Sheep and goat
1.5.4 Pigs
1.5.5 Antelope
1.5.6 Deer
1.5.7 Bison
1.5.8 Camelids
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size
2.1.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue 2014-2025
2.1.2 Global Foot and Mouth Disease (FMD) Vaccine Sales 2014-2025
2.2 Foot and Mouth Disease (FMD) Vaccine Growth Rate by Regions
2.2.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Regions
2.2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Foot and Mouth Disease (FMD) Vaccine Sales by Manufacturers
3.1.1 Foot and Mouth Disease (FMD) Vaccine Sales by Manufacturers
3.1.2 Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Manufacturers
3.1.3 Global Foot and Mouth Disease (FMD) Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Foot and Mouth Disease (FMD) Vaccine Revenue by Manufacturers
3.2.1 Foot and Mouth Disease (FMD) Vaccine Revenue by Manufacturers (2017-2020)
3.2.2 Foot and Mouth Disease (FMD) Vaccine Revenue Share by Manufacturers (2017-2020)
3.3 Foot and Mouth Disease (FMD) Vaccine Price by Manufacturers
3.4 Foot and Mouth Disease (FMD) Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Foot and Mouth Disease (FMD) Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Foot and Mouth Disease (FMD) Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Product
4.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Product
4.3 Foot and Mouth Disease (FMD) Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Foot and Mouth Disease (FMD) Vaccine Breakdown Data by End User
6 North America
6.1 North America Foot and Mouth Disease (FMD) Vaccine by Countries
6.1.1 North America Foot and Mouth Disease (FMD) Vaccine Sales by Countries
6.1.2 North America Foot and Mouth Disease (FMD) Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Foot and Mouth Disease (FMD) Vaccine by Product
6.3 North America Foot and Mouth Disease (FMD) Vaccine by End User
7 Europe
7.1 Europe Foot and Mouth Disease (FMD) Vaccine by Countries
7.1.1 Europe Foot and Mouth Disease (FMD) Vaccine Sales by Countries
7.1.2 Europe Foot and Mouth Disease (FMD) Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Foot and Mouth Disease (FMD) Vaccine by Product
7.3 Europe Foot and Mouth Disease (FMD) Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccine by Countries
8.1.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Countries
8.1.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccine by Product
8.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccine by End User
9 Central & South America
9.1 Central & South America Foot and Mouth Disease (FMD) Vaccine by Countries
9.1.1 Central & South America Foot and Mouth Disease (FMD) Vaccine Sales by Countries
9.1.2 Central & South America Foot and Mouth Disease (FMD) Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Foot and Mouth Disease (FMD) Vaccine by Product
9.3 Central & South America Foot and Mouth Disease (FMD) Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine by Countries
10.1.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales by Countries
10.1.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine by Product
10.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine by End User
11 Company Profiles
11.1 Agrovet market
11.1.1 Agrovet market Company Details
11.1.2 Company Business Overview
11.1.3 Agrovet market Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Agrovet market Foot and Mouth Disease (FMD) Vaccine Products Offered
11.1.5 Agrovet market Recent Development
11.2 Biogénesis Bago
11.2.1 Biogénesis Bago Company Details
11.2.2 Company Business Overview
11.2.3 Biogénesis Bago Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Biogénesis Bago Foot and Mouth Disease (FMD) Vaccine Products Offered
11.2.5 Biogénesis Bago Recent Development
11.3 Vecol
11.3.1 Vecol Company Details
11.3.2 Company Business Overview
11.3.3 Vecol Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Vecol Foot and Mouth Disease (FMD) Vaccine Products Offered
11.3.5 Vecol Recent Development
11.4 FGBI - Federal Centre for Animal Health
11.4.1 FGBI - Federal Centre for Animal Health Company Details
11.4.2 Company Business Overview
11.4.3 FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.4.4 FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Products Offered
11.4.5 FGBI - Federal Centre for Animal Health Recent Development
11.5 Indian Immunologicals
11.5.1 Indian Immunologicals Company Details
11.5.2 Company Business Overview
11.5.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Products Offered
11.5.5 Indian Immunologicals Recent Development
11.6 Merial
11.6.1 Merial Company Details
11.6.2 Company Business Overview
11.6.3 Merial Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Merial Foot and Mouth Disease (FMD) Vaccine Products Offered
11.6.5 Merial Recent Development
11.7 VSVRI
11.7.1 VSVRI Company Details
11.7.2 Company Business Overview
11.7.3 VSVRI Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.7.4 VSVRI Foot and Mouth Disease (FMD) Vaccine Products Offered
11.7.5 VSVRI Recent Development
11.8 FMD Center
11.8.1 FMD Center Company Details
11.8.2 Company Business Overview
11.8.3 FMD Center Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.8.4 FMD Center Foot and Mouth Disease (FMD) Vaccine Products Offered
11.8.5 FMD Center Recent Development
11.9 Limor de Colombia
11.9.1 Limor de Colombia Company Details
11.9.2 Company Business Overview
11.9.3 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Products Offered
11.9.5 Limor de Colombia Recent Development
12 Future Forecast
12.1 Foot and Mouth Disease (FMD) Vaccine Market Forecast by Regions
12.1.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Regions 2019-2025
12.2 Foot and Mouth Disease (FMD) Vaccine Market Forecast by Product
12.2.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Product 2019-2025
12.3 Foot and Mouth Disease (FMD) Vaccine Market Forecast by End User
12.4 North America Foot and Mouth Disease (FMD) Vaccine Forecast
12.5 Europe Foot and Mouth Disease (FMD) Vaccine Forecast
12.6 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Forecast
12.7 Central & South America Foot and Mouth Disease (FMD) Vaccine Forecast
12.8 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Foot and Mouth Disease (FMD) Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
